140410.KQ KOE
Mezzion Pharma Co.,Ltd.
1W: -17.3%
1M: +2.3%
3M: +10.4%
YTD: -55.2%
1Y: +84.5%
3Y: +61.7%
5Y: +51.0%
₩68,000.00 ($50.49)
-5600.00 (-7.61%)
Weekly Expected Move ±9.2%
₩55487
₩61743
₩68000
₩74257
₩80513
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
-$16.6B
+10.3% ▲
Capital Expenditures
$137M
+99.0% ▲
5Y CAGR: -55.6%
Free Cash Flow
-$16.7B
+47.7% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$12.0B
+144.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$13.6B | -$36.3B | -$12.7B | -$19.5B | -$34.9B |
| Depreciation & Amort. | $1.6B | $1.7B | $1.5B | $958M | $988M |
| Stock-Based Comp. | $0 | $1.3B | $0 | $1.2B | $0 |
| Change in Working Capital | -$2.9B | $4.5B | $786M | -$7.1B | -$3.3B |
| Other Non-Cash Items | -$136M | $16.8B | -$627M | $5.9B | $20.6B |
| Operating Cash Flow | -$15.1B | -$12.1B | -$11.0B | -$18.5B | -$16.6B |
| — Investing Activities — | |||||
| Capital Expenditures | -$6.2B | -$1.8B | -$529M | -$590M | -$13.3B |
| Acquisitions (Net) | $0 | $0 | $1.2B | $0 | $270M |
| Investment Purchases | -$32.9B | -$1.1B | -$20.0B | -$15.0B | $0 |
| Investment Sales | $23.0B | $20.3B | $5.0B | $18.0B | $15.0B |
| Other Investing | -$284M | $14M | -$11.3B | -$12.0B | -$111M |
| Investing Cash Flow | -$16.3B | $17.4B | -$25.6B | -$9.6B | $1.9B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$42M | $229M | -$550M | -$500M | $23.0B |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $18.9B | -$1.2B | -$889M | -$556M | -$626M |
| Financing Cash Flow | $19.1B | -$616M | $47.2B | $670M | $26.7B |
| Net Change in Cash | -$11.6B | $5.2B | $10.8B | -$26.6B | $12.0B |
| Cash End of Period | $24.2B | $29.4B | $40.2B | $13.6B | $25.6B |
| Free Cash Flow | -$21.3B | -$13.8B | -$22.9B | -$32.0B | -$16.7B |